JACC: Vitamin C infusion improves microcirculatory reperfusion

In patients undergoing elective PCI, impaired microcirculatory reperfusion is improved by vitamin C infusion, suggesting that oxidative stress is implicated in such a phenomenon, according to a study published in the February issue of the Journal of the American College Cardiology: Cardiovascular Interventions.

Francesco Violi, MD, professor, department of experimental medicine, University of Rome in Italy, and colleagues compared 1 g vitamin C infusion (16.6 mg/min, more than 1 hour before PCI) versus placebo in 56 patients with stable angina.

At the baseline, thrombolysis in myocardial infarction (TIMI) perfusion grade less than 2 was observed in 86 percent of the vitamin C infusion group and 89 percent in the placebo group; the percentages decreased 4 percent in the vitamin C group and 32 percent in the placebo group after PCI, according to Violi and colleagues.

“Complete microcirculatory reperfusion (TIMI grade 3) was achieved in 79 percent of the vitamin C-treated group compared with 39 percent of the placebo group; 8-hydroxy-2-deoxyguanosine  and 8-iso-prostaglandin F2alpha  plasma levels significantly increased in the placebo group while they were significantly reduced in the vitamin C-treated group,” the authors wrote.

Researchers noted that TIMI grade changes from the baseline showed significant correlation with 8-hydroxy-2-deoxyguanosine or 8-iso-prostaglandin F2alpha plasma levels changes.

“Vitamin C has a short half-life and therefore, reperfusion amelioration would probably be a consequence of a short-term effect on arterial dilation; and other mechanisms, such as a decrease of micro-embolization, which would require a prolonged effect, are unlikely but cannot be excluded,” they said.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.